Paw Privileges
Back
Ingredient

Silybin A+B

Also known as: Silybin A+B
General evidence: C

Cited studies

  • Silybin inhibits interleukin-1β-induced production of pro-inflammatory mediators in canine hepatocyte cultures.
    Journal of veterinary pharmacology and therapeutics · 2011
    View source
  • A New Class of Hybrid Anti-inflammatory Agents of Silibinin A Modified Using Gamma Irradiation.
    Chemical & pharmaceutical bulletin · 2025
    View source
  • In-Vitro Activity of Silybin and Related Flavonolignans against Leishmania infantum and L. donovani.
    Molecules (Basel, Switzerland) · 2018
    View source

Products containing Silybin A+B

Educational information only. Not veterinary advice. Always talk to your vet before starting a new supplement.